Tag

primary hyperoxaluria

Phase 3 ePHex Study: OxThera Reports Results

Sid Martin Biotech alum OxThera AB, a biopharma company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces results of its pivotal Phase 3 study.
X